Akela Pharma downsizes to conserve cash for fentanyl programme
This article was originally published in Scrip
Executive Summary
In a bid to conserve cash, Canada's Akela Pharma is restructuring its operations and reducing its headcount by a third. It will close several of its international sites and centralise operations in Austin, Texas, home of its contract services subsidiary PharmaForm.